Retrieve available abstracts of 136 articles: HTML format
Single Articles
March 2025
ABUCAR EAM, Kern M, Kurth T, Meierkord A, et al Health-related quality of life up to 2 years after SARS-CoV-2 infection: a
descriptive cohort study.
Epidemiol Infect. 2025;153:e60. PubMedAbstract available
STERIAN M, Naganathan T, Corrin T, Waddell L, et al Evidence on the associations and safety of COVID-19 vaccination and post COVID-19
condition: an updated living systematic review.
Epidemiol Infect. 2025;153:e62. PubMedAbstract available
CHEN C, Chen D, Du Y, Jiang D, et al Global patterns and trends in deaths of influenza-associated lower respiratory
infections from 1990 to 2019.
Epidemiol Infect. 2025;153:e49. PubMedAbstract available
SUOMENRINNE-NORDVIK A, Leino T, Shubin M, Auranen K, et al Quantifying the direct and indirect components of COVID-19 vaccine effectiveness
during the Delta variant era.
Epidemiol Infect. 2025;153:e59. PubMedAbstract available
MIN KH, Kim JH, Gil JY, Park JH, et al Factors associated with carditis adverse events following SARS-COV-2-19
vaccination.
Epidemiol Infect. 2025;153:e51. PubMedAbstract available
MONGE S, Humphreys J, Nicolay N, Braeye T, et al Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of
the autumnal booster within the VEBIS-EHR network in 2022/23.
Epidemiol Infect. 2025;153:e54. PubMedAbstract available
WITTEVEEN-FREIDL G, Lauenborg Moller K, Voldstedlund M, Gubbels S, et al Data for action - description of the automated COVID-19 surveillance system in
Denmark and lessons learnt, January 2020 to June 2024.
Epidemiol Infect. 2025;153:e58. PubMedAbstract available
WASIK BR, Damodaran L, Maltepes MA, Voorhees IEH, et al THE EVOLUTION AND EPIDEMIOLOGY OF H3N2 CANINE INFLUENZA VIRUS AFTER 20 YEARS IN
DOGS.
Epidemiol Infect. 2025 Mar 5:1-38. doi: 10.1017/S0950268825000251. PubMed
February 2025
Are children and adolescents living with HIV in Europe and South Africa at higher
risk of SARS-CoV-2 and poor COVID-19 outcomes?
Epidemiol Infect. 2025;153:e44. PubMedAbstract available
LIN W, Kung KH, Chan CL, Chuang SK, et al Characteristics and risk factors associated with COVID-19 reinfection in Hong
Kong: a retrospective cohort study.
Epidemiol Infect. 2025;153:e30. PubMedAbstract available
HOEVE CE, Neppelenbroek N, Vos ERA, Huiberts AJ, et al Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
Epidemiol Infect. 2025;153:e38. PubMedAbstract available
SIMMS I, Charlett A, Colon-Gonzalez FJ, Blomquist PB, et al Adapting the Flexible Farrington Algorithm for daily situational awareness and
alert system to support public health decision-making during the SARS-CoV-2
epidemic in England.
Epidemiol Infect. 2025;153:e28. PubMedAbstract available
PASCULLI P, Antonacci M, Zingaropoli MA, Dominelli F, et al SARS-CoV-2 vaccination influence in the development of long-COVID clinical
phenotypes.
Epidemiol Infect. 2025;153:e40. PubMedAbstract available
January 2025
HAYES J, Lee SS, Carnevale J, Shamir D, et al Performance and functional assessment of the Kimera P-IV point-of-care plasmonic
qPCR prototype for ultra rapid pathogen detection of chlamydia trachomatis.
Epidemiol Infect. 2025;153:e27. PubMedAbstract available
CAMPMAN SL, Boyd A, Schinkel J, Coyer L, et al SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam,
The Netherlands, May to November 2022.
Epidemiol Infect. 2025;153:e23. PubMedAbstract available
BEDNARSKA NG, Smith S, Bardsley M, Loveridge P, et al Trends in general practitioner consultations for hand foot and mouth disease in
England between 2017 and 2022.
Epidemiol Infect. 2025;153:e22. PubMedAbstract available
CHANDA MM, Shivachandra SB, Mishra A, Punnoose P, et al Unique duck rearing practice in irrigated rice paddy fields driving recurrent
H5N1 Avian Influenza outbreaks in two districts of Kerala, India.
Epidemiol Infect. 2025 Jan 7:1-36. doi: 10.1017/S0950268824001882. PubMed
BROWN J, Mook P, Vanhaverbeke M, Gimma A, et al Case-only analysis of routine surveillance data: detection of increased vaccine
breakthrough infections with SARS-CoV-2 variants in Europe.
Epidemiol Infect. 2025;153:e16. PubMedAbstract available
December 2024
NOSTAEVA A, Shimansky V, Apalko S, Kuznetsov I, et al Case-control association study between polygenic risk score and COVID-19 severity
in a Russian population using low-pass genome sequencing.
Epidemiol Infect. 2024;153:e13. PubMedAbstract available
TYRRELL GJ, Croxen M, McCullough E, Li V, et al Group A streptococcal infections in Alberta, Canada 2018-2023.
Epidemiol Infect. 2024;153:e35. PubMedAbstract available
ARASHIRO T, Solante R, Sayo AR, Garcia RM, et al Factors associated with COVID-19 in-hospital death and COVID-19 vaccine
effectiveness against COVID-19 hospitalization in the Philippines during
pre-omicron and omicron period: A case-control study (MOTIVATE-P study).
Epidemiol Infect. 2024;153:e18. PubMedAbstract available
HUIBERTS AJ, Oosting IJ, de Melker HE, van de Wijgert JHHM, et al The effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on
neonatal outcomes.
Epidemiol Infect. 2024;153:e5. PubMedAbstract available
ZHENG C, Yu FY, Chan PS, Sun F, et al Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated
with lower odds of long COVID symptoms among people with a history of SARS-CoV-2
infection in Hong Kong, China: a cross-sectional survey study.
Epidemiol Infect. 2024;152:e166. PubMedAbstract available
WANG S, Yan J, Song M, Xue Z, et al Development of a nomogram for high antibody titre of COVID-19 convalescent
plasma.
Epidemiol Infect. 2024;152:e167. PubMedAbstract available
SANOGO IN, Fusade-Boyer M, Molia S, Koita OA, et al Identification of risk areas for avian influenza outbreaks in domestic poultry in
Mali using the GIS-MCDA approach.
Epidemiol Infect. 2024;152:e152. PubMedAbstract available
November 2024
WANG W, Li Q, Wang J A self-driven ESN-DSS approach for effective COVID-19 time series prediction and
modelling.
Epidemiol Infect. 2024;152:e146. PubMedAbstract available
MARKELZ A, Zirnhelt Z, Morris K, Seys SA, et al Association between age of paediatric index cases and household SARS-CoV-2
transmission.
Epidemiol Infect. 2024;152:e145. PubMedAbstract available
SUTER J, Devos I, Matthes KL, Staub K, et al The health and demographic impacts of the "Russian flu" pandemic in Switzerland
in 1889/1890 and in the years thereafter.
Epidemiol Infect. 2024;152:e174. PubMedAbstract available
ZHU W, Tang X, Chen Y, Chen M, et al Prediction of SARS-CoV-2 infection cases based on the meta-SEIRS model.
Epidemiol Infect. 2024;152:e144. PubMedAbstract available
FERRONI E, Mateo-Urdiales A, Bietta C, Cesaroni G, et al Sex differences in response to COVID-19 mRNA vaccines in Italian population.
Epidemiol Infect. 2024;152:e139. PubMedAbstract available
GANDINI S, Conly J, Spencer EA, Evans D, et al Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing
viral culture from gastrointestinal and other potential oro-faecal sources and
evidence for transmission to humans.
Epidemiol Infect. 2024;152:e138. PubMedAbstract available
MAO S, Gu D, Wang D, Li P, et al Prevalence and prognosis of tinnitus in post-COVID-19 patients: a cross-sectional
survey.
Epidemiol Infect. 2024;152:e137. PubMedAbstract available
October 2024
YUN C, Lee Y, Heo SJ, Kim N, et al The impact of COVID-19 status and vaccine type following the first dose on acute
heart disease: A nationwide retrospective cohort study in South Korea.
Epidemiol Infect. 2024;152:e134. PubMedAbstract available
BEDIR DEMIRDAG T, Ozcicek M, Polat M, Kavas FC, et al Effects of COVID-19 pandemic on epidemiological features of viral respiratory
tract infections in children: a single-centre study.
Epidemiol Infect. 2024;152:e128. PubMedAbstract available
PIJNACKER R, Mughini-Gras L, Verhoef L, van den Beld M, et al Impact of non-pharmaceutical interventions during the COVID-19 pandemic on
pathogens transmitted via food in the Netherlands.
Epidemiol Infect. 2024;152:e130. PubMedAbstract available
ZHAO J, Huang X, Li X, Li B, et al The spatial-temporal variations and influencing factors of COVID-19 case fatality
rate: a worldwide study in 30 countries from February 2021 to May 2022.
Epidemiol Infect. 2024;152:e124. PubMedAbstract available
MCKEE CD, Yu EX, Garcia A, Jackson J, et al Superspreading of SARS-CoV-2: a systematic review and meta-analysis of event
attack rates and individual transmission patterns.
Epidemiol Infect. 2024;152:e121. PubMedAbstract available
WANG H, Varol T, Gultzow T, Zimmermann HML, et al Spatio-temporal distributions of COVID-19 vaccine doses uptake in the
Netherlands: a Bayesian ecological modelling analysis.
Epidemiol Infect. 2024;152:e119. PubMedAbstract available
SHAW STEWART PD Will COVID-19 become mild, like a cold?
Epidemiol Infect. 2024;152:e120. PubMedAbstract available
PENDREY CGA, Khvorov A, Nghiem S, Rahaman MR, et al Hospitalizations and emergency attendance averted by influenza vaccination in
Victoria, Australia, 2017 - 2019.
Epidemiol Infect. 2024;152:e111. PubMedAbstract available
CHARLES H, Sinka K, Simms I, Baker KS, et al Trends in shigellosis notifications in England, January 2016 to March 2023.
Epidemiol Infect. 2024;152:e115. PubMedAbstract available
MOORE HL, Turner C, Rawlinson C, Chen C, et al Risk factors for COVID-19 transmission in England: a multilevel modelling study
using routine contact tracing data.
Epidemiol Infect. 2024;152:e112. PubMedAbstract available
September 2024
ANDREYCHYN M, Melnyk L, Zavidniiuk N, Nychyk N, et al Interleukins in the pathogenesis of influenza and other acute respiratory viral
infections.
Epidemiol Infect. 2024;152:e109. PubMedAbstract available
MELTZER HC, Goodwin JL, Fowler LA, Britt TW, et al Severe acute respiratory syndrome coronavirus 2-reactive salivary antibody
detection in South Carolina emergency healthcare workers, September 2019-March
2020.
Epidemiol Infect. 2024;152:e102. PubMedAbstract available
CHARLAND K, Pierce L, Saucier A, Hamelin ME, et al Omicron incidence and seroprevalence among children in Montreal, Canada, in early
2023: final results from the longitudinal EnCORE serology study.
Epidemiol Infect. 2024;152:e103. PubMedAbstract available
August 2024
RIOU J, Studer E, Fesser A, Schuster TM, et al Surveillance of SARS-CoV-2 prevalence from repeated pooled testing: application
to Swiss routine data.
Epidemiol Infect. 2024;152:e100. PubMedAbstract available
June 2024
ALSHAMRANI MM, El-Saed A, Aldayhani O, Alhassan A, et al Risk of central line-associated bloodstream infections during COVID-19 pandemic
in intensive care patients in a tertiary care centre in Saudi Arabia.
Epidemiol Infect. 2024;152:e95. PubMedAbstract available
May 2024
LOVE NK, Jenkins C, McCarthy N, Baker KS, et al International travel as a risk factor for gastrointestinal infections in
residents of North East England.
Epidemiol Infect. 2024;152:e97. PubMedAbstract available
LASANDER M, Elo K, Joronen K, Dub T, et al Barriers to vaccine acceptance in the adult population of mainland Finland, 2021
- ERRATUM.
Epidemiol Infect. 2024;152:e79. PubMed
YI B, Patrasova E, Simunkova L, Rost F, et al Investigating the cause of a 2021 winter wave of COVID-19 in a border region in
eastern Germany: a mixed-methods study, August to November 2021.
Epidemiol Infect. 2024;152:e87. PubMedAbstract available
BERIKOPOULOU MM, Dessypris N, Kalogera E, Petridou E, et al Epidemiology of respiratory syncytial virus in hospitalized children before,
during, and after the COVID-19 lockdown restriction measures in Greece.
Epidemiol Infect. 2024;152:e94. PubMedAbstract available
BEALE S, Yavlinsky A, Fong WLE, Nguyen VG, et al Long-term outcomes of SARS-CoV-2 variants and other respiratory infections:
evidence from the Virus Watch prospective cohort in England.
Epidemiol Infect. 2024;152:e77. PubMedAbstract available
April 2024
PARK JO, Cho HK, Jeon CH, Kim SH, et al Characteristics and biomarkers associated with mortality in COVID-19 patients
presenting to the emergency department.
Epidemiol Infect. 2024;152:e76. PubMedAbstract available
CHAMBERS T, Anglemyer A, Chen A, Atkinson J, et al Population and contact tracer uptake of New Zealand's QR-code-based digital
contact tracing app for COVID-19.
Epidemiol Infect. 2024;152:e66. PubMedAbstract available
TSANG TK, Du RQR, Fang VJ, Lau EHY, et al Decreased risk of non-influenza respiratory infection after influenza B virus
infection in children.
Epidemiol Infect. 2024 Apr 8:1-21. doi: 10.1017/S0950268824000542. PubMed
GUERRERO-SOLER M, Gras-Valenti P, Gomez-Sotero IL, Platas-Abenza G, et al Impact of COVID-19 on the degree of compliance with hand hygiene: a repeated
cross-sectional study.
Epidemiol Infect. 2024;152:e69. PubMedAbstract available
March 2024
NESTERUK I Should we ignore SARS-CoV-2 disease?
Epidemiol Infect. 2024;152:e57. PubMedAbstract available
PENG L, Huang X, Wang C, Xin H, et al Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron
variants in China.
Epidemiol Infect. 2024;152:e43. PubMedAbstract available
MBOUSSOU F, Nkamedjie P, Oyaole D, Farham B, et al Rapid assessment of data systems for COVID-19 vaccination in the WHO African
Region.
Epidemiol Infect. 2024;152:e50. PubMedAbstract available
LOZANO D, Dohoo C, Elfstrom D, Carswell K, et al COVID-19 outbreak at a residential apartment building in Northern Ontario,
Canada.
Epidemiol Infect. 2024;152:e53. PubMedAbstract available
February 2024
YAP WK, Attwell K Medical exemptions to mandatory vaccinations: The state of play in Australia and
a pressure point to watch.
Epidemiol Infect. 2024;152:e40. PubMedAbstract available
HOEG TB, Haslam A, Prasad V The importance of falsification endpoints in observational studies of vaccination
to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2
vaccination of 5- to 11-year-olds.
Epidemiol Infect. 2024;152:e51. PubMedAbstract available
WAITE LL, Nahhas A, Irvahn J, Garden G, et al COVID-19 passenger screening to reduce travel risk and translocation of disease.
Epidemiol Infect. 2024;152:e36. PubMedAbstract available
GARAY E, Whelan SPJ, DuBois RM, O'Rourke SM, et al Immune response to SARS-CoV-2 variants after immunization with different vaccines
in Mexico.
Epidemiol Infect. 2024;152:e30. PubMedAbstract available
January 2024
YAMAYOSHI S, Nagai E, Mitamura K, Hagihara M, et al Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies
between December 2021 and march 2023 in Japan.
Epidemiol Infect. 2024;152:e24. PubMedAbstract available
BIRD O, Galiza EP, Baxter DN, Boffito M, et al The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal
insight.
Epidemiol Infect. 2024;152:e37. PubMedAbstract available
ROSNER BM, Falkenhorst G, Kumpf I, Enssle M, et al Case-control study of behavioural and societal risk factors for sporadic
SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
Epidemiol Infect. 2024;152:e16. PubMedAbstract available
SARKER P, Haq MA, Akhtar E, Roy AK, et al Serosurveillance among urban slum and non-slum populations immunized with
COVID-19 vaccines in Bangladesh.
Epidemiol Infect. 2024;152:e14. PubMedAbstract available
LIEPINS T, Davie G, Miller R, Whitehead J, et al Rural-urban variation in COVID-19 vaccination uptake in Aotearoa New Zealand:
Examining the national roll-out.
Epidemiol Infect. 2024;152:e7. PubMedAbstract available
December 2023
SCHWARTZ RA, Suskind RM Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach
to 'long COVID' with azithromycin.
Epidemiol Infect. 2023;152:e34. PubMedAbstract available
PARRON I, Carol M, Bes N, Izquierdo C, et al The impact of COVID-19 pandemic on the incidence of acute gastroenteritis
outbreaks in Catalonia (Spain).
Epidemiol Infect. 2023;152:e10. PubMedAbstract available
November 2023
ALEEM MA, Macintyre CR, Rahman B, Islam AKMM, et al Association of recent respiratory illness and influenza with acute myocardial
infarction among the Bangladeshi population - a case-control study.
Epidemiol Infect. 2023 Nov 30:1-38. doi: 10.1017/S0950268823001863. PubMed
CHAVES-BLANCO L, de Salazar A, Fuentes A, Vinuela L, et al Evaluation of a combined detection of SARS-CoV-2 and its variants using real-time
allele-specific PCR strategy: an advantage for clinical practice.
Epidemiol Infect. 2023;151:e201. PubMedAbstract available
GULLE BT, Oren MM, Dal T COVID-19 vaccine hesitancy in Turkey: A systematic review and meta-analysis.
Epidemiol Infect. 2023;151:e199. PubMedAbstract available
ELGERSMA IH, Fretheim A, Elstrom P, Aavitsland P, et al Association between face mask use and risk of SARS-CoV-2 infection:
Cross-sectional study.
Epidemiol Infect. 2023;151:e194. PubMedAbstract available
JIANG H, Gu Z, Liu H, Huang J, et al Evaluation of phase-adjusted interventions for COVID-19 using an improved SEIR
model.
Epidemiol Infect. 2023;152:e9. PubMedAbstract available
MERINO P, Kupferwasser D, Flores EA, Phan Tran D, et al Skin and soft tissue infection incidence before and during the COVID-19 pandemic.
Epidemiol Infect. 2023;151:e190. PubMedAbstract available
October 2023
SEGHEZZO G, Nash SG, Aziz NA, Hope R, et al Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1
compared to BA.5 in England.
Epidemiol Infect. 2023;151:e189. PubMedAbstract available
DAVID JA, Kolipakkam B, Morales MK, Vissichelli NC, et al Cell-free plasma next-generation sequencing assists in the evaluation of
secondary pneumonia in patients with COVID-19: a case series.
Epidemiol Infect. 2023;151:e185. PubMedAbstract available
RODRIGUEZ-DEL-RIO FJ, Barroso P, Fernandez-de-Mera IG, de la Fuente J, et al COVID-19 epidemiology and rural healthcare: a survey in a Spanish village.
Epidemiol Infect. 2023;151:e188. PubMedAbstract available
FLANNAGAN J, Chudasama DY, Hope R, Collin SM, et al Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks.
Epidemiol Infect. 2023;151:e191. PubMedAbstract available
KIM JY, Lee WJ, Suh JW, Kim SB, et al Clinical impact of COVID-19 in patients with carbapenem-resistant Acinetobacter
baumannii bacteraemia.
Epidemiol Infect. 2023;151:e180. PubMedAbstract available
WONG R, Lovier MA Racial and ethnic disparities in COVID-19 diagnosis and adherence to mitigation
behaviours in a national United States older adult sample.
Epidemiol Infect. 2023;151:e175. PubMedAbstract available
CANELAS-FERNANDEZ J, Mazagatos C, Delgado-Sanz C, Larrauri A, et al Influenza hospitalizations in Spain between the last influenza and COVID-19
pandemics. 2009-2019.
Epidemiol Infect. 2023 Oct 4:1-32. doi: 10.1017/S0950268823001620. PubMed
ZHENG L, Qiu L, Wu L, Wang J, et al Association of SARS-CoV-2 viral load with abnormal laboratory characteristics and
clinical outcomes in hospitalised COVID-19 patients.
Epidemiol Infect. 2023;151:e173. PubMedAbstract available
September 2023
GOPAL RAO G, Jinjika S, James D, Mukombe N, et al Nosocomial outbreak in a respiratory ward caused by the SARS-CoV-2 Omicron BA
5.2.1 subvariant associated with non-severe illness in vaccinated patients.
Epidemiol Infect. 2023;151:e171. PubMedAbstract available
TWOHIG KA, Harman K, Zaidi A, Aliabadi S, et al Representativeness of whole-genome sequencing approaches in England: the
importance for understanding inequalities associated with SARS-CoV-2 infection.
Epidemiol Infect. 2023;151:e169. PubMedAbstract available
MITANGALA PN, Irenge LM, Musubao ET, Kahindo JBM, et al Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma
markets in the eastern Democratic Republic of the Congo.
Epidemiol Infect. 2023;151:e167. PubMedAbstract available
ZHAO T, Yang Z, Wu Y, Yang J, et al Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A
systematic review and meta-analysis.
Epidemiol Infect. 2023;151:e176. PubMedAbstract available
NDZIESSI G, Niama RF, Aloumba AG, Peya JM, et al Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022.
Epidemiol Infect. 2023;151:e162. PubMedAbstract available
MELLOR J, Overton CE, Fyles M, Chawner L, et al Understanding the leading indicators of hospital admissions from COVID-19 across
successive waves in the UK.
Epidemiol Infect. 2023;151:e172. PubMedAbstract available
August 2023
GUHA SK, Sadhukhan S, Niyogi S COVID-19 cluster identification and support vector machine classifier model
construction using global healthcare and socio-economic features.
Epidemiol Infect. 2023;151:e159. PubMedAbstract available
GOLDSTEIN E Mortality associated with Omicron and influenza infections in France before and
during the COVID-19 pandemic.
Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358. PubMed
SZEKELY J, Rakchang W, Rattanaphan P, Kositpantawong N, et al Fluconazole and echinocandin resistance of Candida species in invasive
candidiasis at a university hospital during pre-COVID-19 and the COVID-19
outbreak.
Epidemiol Infect. 2023;151:e146. PubMedAbstract available
LOVE NK, Douglas A, Gharbia S, Hughes H, et al Understanding the impact of the COVID-19 pandemic response on GI infection
surveillance trends in England, January 2020-April 2022.
Epidemiol Infect. 2023;151:e147. PubMedAbstract available
JENNINGS S, Corrin T, Waddell L A systematic review of the evidence on the associations and safety of COVID-19
vaccination and post COVID-19 condition.
Epidemiol Infect. 2023;151:e145. PubMedAbstract available
SATALA J, Wozniak A, Fabis M, Gorzelak-Pabis P, et al Severe COVID-19 classified by simple covid risk index is associated with higher
levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
Epidemiol Infect. 2023;151:e140. PubMedAbstract available
VERONESE G, Mahamid F, Bdier D Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative
exploration among university students living in the West Bank.
Epidemiol Infect. 2023;151:e139. PubMedAbstract available
July 2023
WALEKHWA AW, Nakazibwe B, Nantongo M, Wafula ST, et al COVID-19 second wave and clinical characteristics of cases in Uganda: A
retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March-June
2021.
Epidemiol Infect. 2023;151:e142. PubMedAbstract available
HALEVI A, Shkalim Zemer V, Embar T, Jacobson E, et al Attitudes toward COVID-19 vaccination of healthcare workers in Israel and
vaccination rates during vaccine rollout.
Epidemiol Infect. 2023;151:e132. PubMedAbstract available
DE CARVALHO FS, Slack SD, Barbosa-Junior F, de Campos MR, et al Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the
UnCoVER-Brazil project.
Epidemiol Infect. 2023;151:e126. PubMedAbstract available
FUNK T, Espenhain L, Moller FT, Ethelberg S, et al Factors associated with the formation of SARS-CoV-2 case-clusters in Danish
schools: a nationwide register-based observational study.
Epidemiol Infect. 2023;151:e168. PubMedAbstract available
GERRITZEN I, Brus IM, Spronk I, Biere-Rafi S, et al Identification of post-COVID-19 condition phenotypes, and differences in
health-related quality of life and healthcare use: a cluster analysis.
Epidemiol Infect. 2023;151:e123. PubMedAbstract available
BLACKBURN AM, Han H, Gallegos A Cross-language validation of COVID-19 Compliance Scale in 28 languages.
Epidemiol Infect. 2023;151:e119. PubMedAbstract available
ROGERS JH, Cox SN, Link AC, Nwanne G, et al Incidence of SARS-CoV-2 infection and associated risk factors among staff and
residents at homeless shelters in King County, Washington: an active surveillance
study.
Epidemiol Infect. 2023;151:e129. PubMedAbstract available
HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal
carriage and disease in the UK - ERRATUM.
Epidemiol Infect. 2023;151:e108. PubMed
KULIMBET M, Saliev T, Alimbekova G, Ospanova D, et al Study of seroprevalence of SARS-CoV-2 in Kazakhstan.
Epidemiol Infect. 2023;151:e116. PubMedAbstract available
RIEKKINEN M, Kajova M, Eriksson M, Luukkainen A, et al Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults:
symptomatic COVID-19 only contracted by those without recent infection.
Epidemiol Infect. 2023;151:e113. PubMedAbstract available
TOAN DTT, Pham TH, Nguyen KC, Pham QT, et al Shift from a Zero-COVID strategy to a New-normal strategy for controlling
SARS-COV-2 infections in Vietnam.
Epidemiol Infect. 2023;151:e117. PubMedAbstract available
June 2023
GUO Y, Zeng X, Li L, Wang L, et al The impact of HBV infection on clinical outcomes of COVID-19 patients: a
systematic review and meta-analysis.
Epidemiol Infect. 2023;151:e135. PubMedAbstract available
LUO Y, Li Y, Xiao S, Lei H, et al Comparative analysis of inflight transmission of SARS-CoV-2, influenza, and
SARS-CoV-1.
Epidemiol Infect. 2023 Jun 23:1-22. doi: 10.1017/S0950268823001012. PubMed
RAPTI I, Asimakopoulos A, Liontos A, Kosmidou M, et al Association of patient characteristics with clinical outcomes in a cohort of
hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for
COVID-19 - Corrigendum.
Epidemiol Infect. 2023;151:e91. PubMed
LEOPARDI S, Desiato R, Mazzucato M, Orusa R, et al One health surveillance strategy for coronaviruses in Italian wildlife.
Epidemiol Infect. 2023;151:e96. PubMedAbstract available
HADLEY L, Karachaliou Prasinou A, Christensen H, Ramsay M, et al Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal
carriage and disease in the UK.
Epidemiol Infect. 2023;151:e98. PubMedAbstract available
May 2023
HSU CY, Chen JK, Wikramaratna PS, Yen AM, et al Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian
meta-analysis.
Epidemiol Infect. 2023;151:e99. PubMedAbstract available
SABIR QUA, Shafqat A, Aslam M Prediction of the COVID-19 transmission: a case study of Pakistan.
Epidemiol Infect. 2023;151:e89. PubMedAbstract available
LUO E, Zhong Q, Wen Y, Cai J, et al Development and external validation of a prognostic tool for nonsevere COVID-19
inpatients.
Epidemiol Infect. 2023;151:e128. PubMedAbstract available
CHANG H, Zhang X, Su H, Cai J, et al Epidemiological characteristics of paediatric Omicron infection during the
outbreak of SARS-CoV-2 infection during March-May in 2022 in Shanghai, China.
Epidemiol Infect. 2023;151:e81. PubMedAbstract available
SCHOEPS A, Walter J, Vogt M, Bent S, et al Direct and indirect vaccination effects on SARS-CoV-2 infection in day-care
centres: Evaluating the policy for early vaccination of day-care staff in
Germany, 2021.
Epidemiol Infect. 2023;151:e80. PubMedAbstract available
SHI T, Huang L Prevalence of respiratory pathogens and risk of developing pneumonia under
non-pharmaceutical interventions in Suzhou, China.
Epidemiol Infect. 2023;151:e82. PubMedAbstract available
April 2023
JOVANOVIC V, Milic M, Dotlic J, Cvjetkovic S, et al Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated
people in Serbia.
Epidemiol Infect. 2023;151:e83. PubMedAbstract available
FRILLI E, Amodeo D, Cevenini G, Nante N, et al Effectiveness of near-UVA in SARS-CoV-2 inactivation.
Epidemiol Infect. 2023;151:e76. PubMedAbstract available
MERCKX J, Callies M, Kabouche I, Desombere I, et al SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among
pupils and school staff: a prospective cohort study.
Epidemiol Infect. 2023;151:e75. PubMedAbstract available
WHITEHEAD J, Gan H, Heerikhuisen J, Gray G, et al Inequities in COVID-19 Omicron infections and hospitalisations for Maori and
Pacific people in Te Manawa Taki Midland region, New Zealand.
Epidemiol Infect. 2023;151:e74. PubMedAbstract available
ALHARBI B, Jennison AV, Hicks V, Whiley DM, et al Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19
restrictions in Queensland, Australia 2020.
Epidemiol Infect. 2023;151:e67. PubMedAbstract available
PRABHU VG, Hand WR, Isik T, Song Y, et al Risk-adjusted policies to minimise perioperative staffing shortages during a
pandemic: An agent-based simulation study.
Epidemiol Infect. 2023;151:e66. PubMedAbstract available
AHMED A, DeWitt ME, Dantuluri KL, Castri P, et al Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children
and adolescents in North Carolina.
Epidemiol Infect. 2023;151:e63. PubMedAbstract available
March 2023
GOODWIN B, Zia H, Lo DF Assessment of early and post COVID-19 vaccination antibody response in healthcare
workers: a critical review.
Epidemiol Infect. 2023;151:e52. PubMed
ALLEN H, Tessier E, Turner C, Anderson C, et al Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2)
variants and the impact of vaccination: national cohort study, England.
Epidemiol Infect. 2023;151:e58. PubMedAbstract available
MIZOUE T, Yamamoto S, Oshiro Y, Inamura N, et al Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical
research centre in Tokyo after the emergence of variants.
Epidemiol Infect. 2023;151:e48. PubMedAbstract available
February 2023
CAPELASTEGUI F, Flannagan J, Augarde E, Tessier E, et al Making the invisible visible: using national surveillance data to identify people
experiencing homelessness in England with COVID-19.
Epidemiol Infect. 2023;151:e51. PubMedAbstract available
SALAMA M, Amitai Z, Sheffer R Demographic and clinical characteristics of children and adolescents hospitalised
with laboratory-confirmed COVID-19 in the Tel-Aviv District, Israel, 2020-2022.
Epidemiol Infect. 2023;151:e42. PubMedAbstract available
ZHOU Y, Li Z, Wu W, Xiao J, et al Transmission trends of the global COVID-19 pandemic with combined effects of
adaptive behaviours and vaccination.
Epidemiol Infect. 2023;151:e39. PubMedAbstract available
HU CY, Lei Y, Tang YW, Cui WS, et al Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering
from COVID-19.
Epidemiol Infect. 2023;151:e34. PubMedAbstract available
MAIER BF, Rose AH, Burdinski A, Klamser P, et al Estimating the share of SARS-CoV-2-immunologically naive individuals in Germany
up to June 2022.
Epidemiol Infect. 2023;151:e38. PubMedAbstract available
December 2022
WARD T, Glaser A, Overton CE, Carpenter B, et al Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron
variants of SARS-CoV-2.
Epidemiol Infect. 2022;151:e32. PubMedAbstract available